Tg(C9orf72*)19Lagi
Transgene Detail
|
Symbol: |
Tg(C9orf72*)19Lagi |
Name: |
transgene insertion 19, Clotilde Lagier-Tourenne |
MGI ID: |
MGI:6100942 |
Synonyms: |
C919 |
Transgene: |
Tg(C9orf72*)19Lagi Location: unknown
|
Alliance: |
Tg(C9orf72*)19Lagi page
|
|
Strain of Origin: |
C57BL/6 x C3H
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(C9orf72*)19Lagi expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
C9orf72 (203228) |
|
BAC subclone contains a contraction to 90 or 450 GGGGCC repeats |
|
|
|
Mutation details: The transgenic construct is constructed with a ~156 kbp human bacterial artificial chromosome (BAC) CH523-111K12 (Chr9:27,561,110-27,714,308; May 2016) containing the human C9ALS patient-derived C9orf72 gene encoding a truncated short C9ORF72 isoform (222 aa; exons 1-5 with TAA site and polyA signal) with hexanucleotide repeat expansions (GGGGCC) in intron 1a. The BAC has ~140 kbp of transcriptionally-upstream (telomeric) flanking sequences that contain no other confirmed genes. Founder line C9<19> (called line 19) was identified with multiple transgene copies at the same locus that segregate together - with each transgene copy containing either ~90 or ~450 hexanucleotide repeat lengths.
(J:232242)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:232242 Jiang J, et al., Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016 May 4;90(3):535-50 |
All: |
2 reference(s) |
|